MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
AXLA Axcella Health
- 0.4009
- 0.00000.00%
Close Jan 11 16:00 ET
1.18MMarket Cap-0.02P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.4009Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)2.95MShares0.510052wk High-0.52P/B530.37KFloat Cap0.340052wk Low--Dividend TTM1.32MShs Float399.7500Historical High--Div YieldTTM0.00%Amplitude0.3400Historical Low--Avg Price1Lot Size
Axcella Health Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 80.41%-3.66M | 69.72%-5.11M | -28.34%-69.59M | -13.94%-15.54M | -51.60%-18.52M | -31.25%-18.67M | -19.21%-16.86M | -8.94%-54.22M | -35.52%-13.64M | -14.62%-12.22M |
| Net income from continuing operations | 83.98%-3.41M | 79.12%-3.98M | -25.62%-81.19M | -28.56%-23M | -14.27%-17.84M | -33.71%-21.31M | -25.35%-19.04M | -14.33%-64.63M | -17.79%-17.89M | -25.54%-15.61M |
| Operating gains losses | --0 | ---68K | --1.6M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -87.80%10K | -85.71%11K | 43.06%412K | 62.67%122K | 61.73%131K | 20.59%82K | 20.31%77K | -31.26%288K | -1.32%75K | -11.96%81K |
| Other non cash items | -323.86%-394K | -267.86%-376K | -66.95%507K | -107.08%-31K | -60.80%138K | -56.33%176K | -34.31%224K | 116.67%1.53M | 23.73%438K | 295.51%352K |
| Change In working capital | -116.06%-287K | -436.51%-1.24M | 35.10%3.16M | 28.15%2.91M | -246.53%-1.9M | 510.80%1.79M | 146.51%367K | 455.93%2.34M | -31.95%2.27M | 476.00%1.3M |
| -Change in prepaid assets | 76.57%-183K | 39.69%887K | 668.09%722K | 1,279.22%908K | 84.19%-40K | -168.38%-781K | -11.19%635K | 145.85%94K | -110.55%-77K | -209.05%-253K |
| -Change in payables and accrued expense | -104.05%-104K | -691.79%-2.12M | 8.63%2.44M | -14.74%2M | -220.01%-1.86M | 1,883.33%2.57M | 82.18%-268K | 596.25%2.25M | -9.94%2.35M | 22,228.57%1.55M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 80.41%-3.66M | 69.72%-5.11M | -28.34%-69.59M | -13.94%-15.54M | -51.60%-18.52M | -31.25%-18.67M | -19.21%-16.86M | -8.94%-54.22M | -35.52%-13.64M | -14.62%-12.22M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -96.01%525K | 914.87%30.92M | -100.23%-19K | 113.16%10.17M | 71.52%7.61M | 191.44%13.16M | 108.44%3.05M | 125.04%8.23M | 249.28%4.77M |
| Net PPE purchase and sale | --0 | 420.12%525K | -54.91%-426K | ---19K | -1,076.19%-205K | 84.55%-38K | -228.00%-164K | -38.19%-275K | --0 | --21K |
| Net investment purchase and sale | --0 | --0 | 843.68%31.35M | --0 | 118.42%10.38M | 63.32%7.65M | 192.90%13.32M | 109.25%3.32M | 125.15%8.23M | 248.62%4.75M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | -96.01%525K | 914.87%30.92M | -100.23%-19K | 113.16%10.17M | 71.52%7.61M | 191.44%13.16M | 108.44%3.05M | 125.04%8.23M | 249.28%4.77M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -100.11%-27K | 920.84%32.24M | 151.87%7.28M | 25.31%-301K | -108.59%-58K | 633,050.00%25.32M | -95.17%3.16M | 536.56%2.89M | -106.11%-403K |
| Net issuance payments of debt | --0 | 37.21%-27K | -15,357.25%-20.25M | -47,778.57%-20.11M | -11.90%-47K | -6.38%-50K | ---43K | ---131K | ---42K | ---42K |
| Net common stock issuance | --0 | --0 | 1,019.38%53.5M | 881.60%28.06M | -101.86%-25K | -94.81%30K | --25.43M | -92.68%4.78M | 719.20%2.86M | -79.64%1.34M |
| Proceeds from stock option exercised by employees | --0 | --0 | -22.88%182K | 26.03%92K | --0 | -25.66%84K | -77.78%6K | 63.89%236K | -49.31%73K | --23K |
| Net other financing activities | ---- | ---- | 31.05%-1.19M | ---768K | ---229K | ---122K | -129.03%-71K | -4,325.64%-1.73M | --0 | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | -100.11%-27K | 920.84%32.24M | 151.87%7.28M | 25.31%-301K | -108.59%-58K | 633,050.00%25.32M | -95.17%3.16M | 536.56%2.89M | -106.11%-403K |
| Net cash flow | ||||||||||
| Beginning cash position | -72.25%12.54M | -27.26%17.15M | -67.07%23.57M | -2.55%25.43M | 0.40%34.08M | 4.97%45.19M | -67.07%23.57M | -22.23%71.59M | -77.13%26.09M | -72.03%33.94M |
| Current changes in cash | 67.10%-3.66M | -121.31%-4.61M | 86.61%-6.43M | -228.88%-8.28M | -10.23%-8.65M | -22.00%-11.11M | 175.74%21.62M | -134.65%-48.02M | 94.07%-2.52M | -8.07%-7.85M |
| End cash Position | -73.93%8.88M | -72.25%12.54M | -27.26%17.15M | -27.26%17.15M | -2.55%25.43M | 0.40%34.08M | 4.97%45.19M | -67.07%23.57M | -67.07%23.57M | -77.13%26.09M |
| Free cash flow | 80.45%-3.66M | 70.02%-5.11M | -28.48%-70.01M | -14.08%-15.56M | -53.54%-18.73M | -29.29%-18.71M | -19.94%-17.03M | -8.97%-54.5M | -33.13%-13.64M | -14.42%-12.2M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.